Nadroparin - Compound Summary (CID 25244225)
Also known as: Nadroparine, Clivarin, Liquaemin, Reviparin, Reviparin sodium, Dalteparin sodium, Kabi 2165, Multiparin, Novoheparin
Molecular Formula: C12H17NO20S3-4   Molecular Weight: 591.45308   InChIKey: OHJKXVLJWUPWQG-IUYNYSEKSA-J
Dalteparin, a low molecular weight heparin (LMWH) prepared by nitrous acid degradation of unfractionated heparin of porcine intestinal mucosa origin, is an anticoagulant. It is composed of strongly acidic sulphated polysaccharide chains with an average molecular weight of 5000 and about 90% of the material within the range of 2000-9000. LMWHs have a more predictable response, a greater bioavailability, and a longer anti-Xa half life than unfractionated heparin. Dalteparin can also be safely used in most pregnant women. Low molecular weight heparins are less effective at inactivating factor IIa due to their shorter length compared to unfractionated heparin.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Biomedical Effects and Toxicity
Safety and Handling
Environmental Fate and Exposure Potential
Exposure Standards and Regulations
Monitoring and Analysis Methods
Literature
Biomolecular Interactions and Pathways
Classification
Chemical and Physical Properties
_ _